CLINICAL_TRIALS
trial_result
· 2016-11-04
Clinical Trial Update: Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis [Phase 3]
Summary
A Phase 3 trial evaluating intravenous immunoglobulin to prevent sepsis in preterm neonates has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hormozgan University of Medical Sciences | Conditions: Neonatal Sepsis | Phase 3 | Status: COMPLETED